hotspot -WSS

hotspot

author：comprehensive 2025-09-30 00:00:59 - browse：5155

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Medicare drug price negotiation’s day in court

WSS

Cybersecurity threat forces Lurie Children's to take systems offline

General Catalyst, Summa Health deal will turn on physician buy

Apple Vision Pro: A first look at health apps on the new VR headset

How doctors and nurses shape Google's AI

Covid misinformation case heads to Supreme Court

Peter Marks talks Operation Warp Speed for Rare Diseases

entertainment

hotspot

leisure time

United colonoscopy coverage change 'may cost lives,' doctors say

Takeaways from AdvaMed, the largest medical devices conference

Anesthesiologist group: stop taking Ozempic before surgery

Novo Nordisk to expand supply of Wegovy for U.S. patients

Trump demands the U.S. pay no more for drugs than other countries … again

European regulators recommend Amylyx's ALS drug be rejected

As demand for Covid shots wanes, Moderna seeks its next success

Apple Vision Pro: A first look at health apps on the new VR headset

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New Ultima Genomics DNA sequencer can read genome for $100

knowledge

Quicker fix for pulse oximeters urged during FDA public meeting

There’s no way to know how good AI health technologies are

Bernie Sanders bashes nonprofit hospitals over their tax breaks

New Ultima Genomics DNA sequencer can read genome for $100

European regulators recommend Amylyx's ALS drug be rejected

STAT Readout Newsletter: Today in biotech, life science news

hotspot

hotspot

focus

hotspot